Variable | R | SE | OR (95% CI) | p |
---|---|---|---|---|
RBC (*1012/L) | -1.148 | 0.174 | 0.317 (0.226–0.446) | < 0.001 |
NEU% | 0.026 | 0.008 | 1.027 (1.010–1.043) | 0.001 |
PLT | 0.003 | 0.001 | 1.003 (1.000–1.006) | 0.029 |
Gender (“Female” for reference) | -0.691 | 0.207 | 0.501 (0.334–0.752) | < 0.001 |
Metastatic site (“Liver” for reference) | 0.407 | 0.181 | 1.502 (1.054–2.140) | 0.024 |
Daily IM dose (“ ≤ 200mg/d” for reference) | 0.007 | |||
300mg/d | 1.158 | 0.596 | 3.185 (0.991–10.235) | |
400mg/d | 1.779 | 0.546 | 5.923 (2.030–17.281) | |
500mg/d | 1.556 | 0.631 | 4.740 (1.375–16.341) | |
≥ 600mg/d | 2.014 | 0.732 | 7.490 (1.784–31.445) |